DABT

Dr. Christian is a regulatory toxicologist with over 30 years of experience in the contract pharmaceutical research industry.  Prior to joining OSOD he served as the scientific lead for the ocular toxicology services offered at Covance/Labcorp Laboratories which included planning and directing nonclinical toxicology and pharmacology studies as senior study director.  Brian is a diplomate of the American Board of Toxicology and has served on the Executive Committee of the Ocular Toxicology Specialty Section of the Society of Toxicology.    

Dr. O'Neill serves as a member of the Executive Board and provides consulting on many aspects of vision science with a specific focus on drug development and nonclinical considerations for regulatory submissions.  Dr. O’Neill has 30 years of biotechnology and pharmaceutical development experience.  Currently, he is a Co-Founder, Chief Executive Officer and Board Chair at MCAL Therapeutics, Inc. that is developing a novel evaporative dry eye therapy. From 2004 to 2023 Dr.